Lam Research Corporation Reports Financial Results for the Quarter Ended December 28, 2025
Rhea-AI Summary
Lam Research (Nasdaq: LRCX) reported results for the quarter ended December 28, 2025: revenue $5.34 billion, U.S. GAAP gross margin 49.6%, U.S. GAAP operating income 33.9% of revenue, and U.S. GAAP diluted EPS $1.26. Non-GAAP diluted EPS was $1.27.
Cash and cash equivalents were $6.18 billion, deferred revenue was $2.25 billion. Geographic mix: China 35%, Taiwan 20%, Korea 20%, Japan 10%. Systems revenue was $3.36 billion; customer support revenue was $1.99 billion. Outlook for March 29, 2026: revenue $5.70 billion +/- $300 million, gross margin ~49.0% +/-1%, EPS $1.35 +/- $0.10.
Positive
- Revenue +22% year-over-year for the December quarter to $5.34B
- Gross margin improved +220 bps year-over-year to 49.6%
- Six-month revenue +25% year-over-year to $10.67B
Negative
- Deferred revenue decreased 18.7% quarter-over-quarter to $2.25B
- Cash and cash equivalents declined $512.6M quarter-over-quarter to $6.18B
News Market Reaction
On the day this news was published, LRCX gained 0.47%, reflecting a mild positive market reaction. Argus tracked a peak move of +3.4% during that session. Our momentum scanner triggered 41 alerts that day, indicating elevated trading interest and price volatility. This price movement added approximately $1.41B to the company's valuation, bringing the market cap to $300.92B at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
LRCX gained 7% while key peers also traded higher: AMAT +2.55%, KLAC +3.51%, TER +0.93%, ASML +2.61%, ENTG +2.51%. Direction aligns, but scanner did not flag a sector-wide momentum event.
Previous Earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Oct 22 | Quarterly earnings | Positive | -2.6% | Reported Q3 2025 results with $5.32B revenue and strong margins, but shares fell. |
| Jul 30 | Quarterly earnings | Positive | -4.3% | Q2 2025 revenue $5.17B with expanding margins and EPS, yet stock declined. |
| Apr 23 | Quarterly earnings | Positive | +6.3% | Q1 2025 revenue $4.72B and higher margins drove a positive price reaction. |
| Jan 29 | Quarterly earnings | Positive | +7.4% | Q4 2024 revenue $4.38B and EPS growth supported a strong next-day gain. |
| Oct 23 | Quarterly earnings | Positive | +5.1% | Q3 2024 results with $4.17B revenue and margin improvement lifted shares. |
Earnings releases often produce sizable moves for LRCX, with a mix of aligned rallies and occasional sell-the-news reactions despite generally strong results.
Recent history shows Lam delivering consistent growth: revenue rose from $4.17B in Q3 2024 to $4.38B, $4.72B, $5.17B, and $5.32B ahead of the current $5.34B quarter. Gross margins have generally held near the high-40% to low-50% range, while China has remained the largest regional contributor. Past earnings reactions were mixed, with several strong post-print rallies but also a few negative moves, indicating expectations sensitivity even when reported metrics are solid.
Historical Comparison
In the past 5 earnings releases, LRCX moved an average of 5.13%. Today’s 7% post-earnings move is somewhat larger but still consistent with its usual earnings volatility.
Earnings releases reflect a steady revenue climb from $4.17B in Q3 2024 to $5.32B in September 2025 and now $5.34B, with margins generally holding near 49–50% and China remaining the largest regional driver.
Regulatory & Risk Context
Lam has an effective S-3ASR shelf registration dated Aug 11, 2025, permitting issuance of various securities (debt, common, preferred, warrants, rights and units) for general corporate purposes. Authorized capital includes 4,000,000,000 common and 5,000,000 preferred shares, with 1,265,620,604 common shares outstanding as of Aug 7, 2025.
Market Pulse Summary
This announcement details another robust quarter, with revenue of $5.34B, GAAP diluted EPS of $1.26, and guidance for $5.70B next-quarter revenue. Margins remain near 50% and customer support-related revenue continues to grow. Historically, Lam’s earnings reports have triggered meaningful moves, both up and down. Investors may watch upcoming quarters against this guidance, monitor capital allocation under the existing S-3ASR shelf, and track regional demand trends, particularly from China and Korea.
Key Terms
non-gaap financial
deferred revenue financial
basis points financial
rule 10b5-1 trading plan regulatory
form 4 regulatory
safe harbor regulatory
amortization of debt discounts financial
AI-generated analysis. Not financial advice.
Highlights for the December 2025 quarter were as follows:
- Revenue of
.$5.34 billion U.S. GAAP gross margin of49.6% ,U.S. GAAP operating income as a percentage of revenue of33.9% , andU.S. GAAP diluted EPS of .$1.26 - Non-GAAP gross margin of
49.7% , non-GAAP operating income as a percentage of revenue of34.3% , and non-GAAP diluted EPS of .$1.27
Key Financial Data for the Quarters Ended December 28, 2025 and September 28, 2025 (in thousands, except per-share data, percentages, and basis points) | ||||||
December 2025 | September 2025 | Change Q/Q | ||||
Revenue | $ 5,344,791 | $ 5,324,173 | — | |||
Gross margin as percentage of revenue | 49.6 % | 50.4 % | - 80 bps | |||
Operating income as percentage of revenue | 33.9 % | 34.4 % | - 50 bps | |||
Diluted EPS | $ 1.26 | $ 1.24 | + 2 % | |||
Non-GAAP | ||||||
December 2025 | September 2025 | Change Q/Q | ||||
Revenue | $ 5,344,791 | $ 5,324,173 | — | |||
Gross margin as percentage of revenue | 49.7 % | 50.6 % | - 90 bps | |||
Operating income as percentage of revenue | 34.3 % | 35.0 % | - 70 bps | |||
Diluted EPS | $ 1.27 | $ 1.26 | + 1 % | |||
For the December 2025 quarter, revenue was
Non-GAAP Financial Results
For the December 2025 quarter, non-GAAP gross margin was
"Lam delivered another strong quarter to cap a record year," said Tim Archer, Lam Research's President and Chief Executive Officer. "Entering 2026, our expanding product and services portfolio is enabling the market's transition to smaller, more complex three-dimensional devices and packages. With AI accelerating, we are ramping execution velocity across the company to support our customers' growth and realize our vision for multi-year outperformance."
Balance Sheet and Cash Flow Results
Cash, cash equivalents, and restricted cash balances decreased to
Deferred revenue at the end of the December 2025 quarter decreased to
Revenue
The geographic distribution of revenue during the December 2025 quarter is shown in the following table:
Region | Revenue |
35 % | |
20 % | |
20 % | |
10 % | |
8 % | |
5 % | |
2 % |
The following table presents revenue disaggregated between systems and customer support-related revenue:
Three Months Ended | |||||
December 28, | September 28, | December 29, | |||
(In thousands) | |||||
Systems revenue | $ 3,357,493 | $ 3,547,565 | $ 2,625,649 | ||
Customer support-related revenue and other | 1,987,298 | 1,776,608 | 1,750,398 | ||
$ 5,344,791 | $ 5,324,173 | $ 4,376,047 | |||
Systems revenue includes sales of new leading-edge equipment in deposition, etch, and other wafer fabrication markets.
Customer support-related revenue includes sales of customer service, spares, upgrades, and non-leading-edge equipment from our Reliant® product line.
Outlook
For the quarter ending March 29, 2026, Lam is providing the following guidance:
Reconciling | Non-GAAP | |||||||||
Revenue | +/- | — | +/- | |||||||
Gross margin as a percentage of revenue | 49.0 % | +/- | 1 % | $ 2.7 | Million | 49.0 % | +/- | 1 % | ||
Operating income as a percentage of revenue | 33.9 % | +/- | 1 % | $ 3.0 | Million | 34.0 % | +/- | 1 % | ||
Net income per diluted share | +/- | $ 3.5 | Million | +/- | ||||||
Diluted share count | 1.26 Billion | — | 1.26 Billion | |||||||
The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, other investments, or other items that may be completed or realized after the date of this release, except as described below.
- Gross margin as a percentage of revenue - amortization related to intangible assets acquired through business combinations,
.$2.7 million - Operating income as a percentage of revenue - amortization related to intangible assets acquired through business combinations,
.$3.0 million - Net income per diluted share - amortization related to intangible assets acquired though business combinations,
; amortization of debt discounts,$3.0 million ; and associated tax benefit for non-GAAP items ($0.7 million ); totaling$0.2 million .$3.5 million
Use of Non-GAAP Financial Results
In addition to
Management uses non-GAAP gross margin, operating expense, operating income, operating income as a percentage of revenue, net income, and net income per diluted share to evaluate the Company's operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors' ability to view the Company's results from management's perspective. Tables presenting reconciliations of non-GAAP results to
Caution Regarding Forward-Looking Statements
Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to: our outlook and guidance for future financial results, including revenue, gross margin, operating income and net income; the size of our product and services portfolio; the extent to which our products and services are enabling our customers; customer and industry trends, including the role of AI as an industry driver; our rate of operational execution; and our long-term performance objectives. Some factors that may affect these forward-looking statements include: business, economic, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; trade regulations, export controls, tariffs, trade disputes, and other geopolitical tensions may inhibit our ability to sell our products; supply chain cost increases, tariffs, export controls and other inflationary pressures have impacted and may continue to impact our profitability; supply chain disruptions, export controls or manufacturing capacity constraints may limit our ability to manufacture and sell our products; and natural and human-caused disasters, disease outbreaks, war, terrorism, political or governmental unrest or instability, or other events beyond our control may impact our operations and revenue in affected areas; as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our annual report on Form 10-K for the fiscal year ended June 29, 2025 and our quarterly report on Form 10-Q for the fiscal quarter ended September 28, 2025. These uncertainties and changes could materially affect the forward-looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this release.
Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam's equipment and services allow customers to build smaller and better performing devices. In fact, today, nearly every advanced chip is built with Lam technology. We combine superior systems engineering, technology leadership, and a strong values-based culture, with an unwavering commitment to our customers. Lam Research (Nasdaq: LRCX) is a FORTUNE 500® company headquartered in
Consolidated Financial Tables Follow.
LAM RESEARCH CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share data and percentages) (unaudited) | |||||||||
Three Months Ended | Six Months Ended | ||||||||
December 28, | September 28, | December 29, | December 28, | December 29, | |||||
Revenue | $ 5,344,791 | $ 5,324,173 | $ 4,376,047 | $ 8,544,023 | |||||
Cost of goods sold | 2,693,629 | 2,639,294 | 2,303,066 | 5,332,923 | 4,468,359 | ||||
Gross margin | 2,651,162 | 2,684,879 | 2,072,981 | 5,336,041 | 4,075,664 | ||||
Gross margin as a percent of revenue | 49.6 % | 50.4 % | 47.4 % | 50.0 % | 47.7 % | ||||
Research and development | 573,305 | 576,446 | 494,947 | 1,149,751 | 990,305 | ||||
Selling, general and administrative | 267,654 | 279,345 | 244,150 | 546,999 | 487,278 | ||||
Total operating expenses | 840,959 | 855,791 | 739,097 | 1,696,750 | 1,477,583 | ||||
Operating income | 1,810,203 | 1,829,088 | 1,333,884 | 3,639,291 | 2,598,081 | ||||
Operating income as a percent of revenue | 33.9 % | 34.4 % | 30.5 % | 34.1 % | 30.4 % | ||||
Other income (expense), net | 26,410 | 30,074 | 14,262 | 56,484 | 44,343 | ||||
Income before income taxes | 1,836,613 | 1,859,162 | 1,348,146 | 3,695,775 | 2,642,424 | ||||
Income tax expense | (242,619) | (290,502) | (157,128) | (533,121) | (334,962) | ||||
Net income | $ 1,593,994 | $ 1,568,660 | $ 1,191,018 | $ 3,162,654 | $ 2,307,462 | ||||
Net income per share: | |||||||||
Basic | $ 1.27 | $ 1.24 | $ 0.93 | $ 2.51 | $ 1.78 | ||||
Diluted | $ 1.26 | $ 1.24 | $ 0.92 | $ 2.50 | $ 1.78 | ||||
Number of shares used in per share calculations: | |||||||||
Basic | 1,254,856 | 1,264,446 | 1,287,109 | 1,259,651 | 1,293,173 | ||||
Diluted | 1,261,739 | 1,269,313 | 1,291,469 | 1,265,526 | 1,297,767 | ||||
Cash dividend declared per common share | $ 0.26 | $ 0.26 | $ 0.23 | $ 0.52 | $ 0.46 | ||||
LAM RESEARCH CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands) | |||||
December 28, | September 28, | June 29, | |||
(unaudited) | (unaudited) | (1) | |||
ASSETS | |||||
Cash and cash equivalents | $ 6,180,440 | $ 6,693,046 | $ 6,390,659 | ||
Accounts receivable, net | 3,491,987 | 3,633,034 | 3,378,071 | ||
Inventories | 4,037,682 | 4,095,054 | 4,307,991 | ||
Prepaid expenses and other current assets | 307,914 | 385,580 | 440,274 | ||
Total current assets | 14,018,023 | 14,806,714 | 14,516,995 | ||
Property and equipment, net | 2,710,989 | 2,510,531 | 2,428,744 | ||
Goodwill and intangible assets | 1,864,037 | 1,826,950 | 1,808,685 | ||
Other assets | 2,798,122 | 2,756,016 | 2,590,836 | ||
Total assets | $ 21,391,171 | $ 21,900,211 | $ 21,345,260 | ||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||
Current portion of long-term debt and finance lease obligations | $ 754,006 | $ 754,363 | $ 754,311 | ||
Other current liabilities | 5,459,147 | 5,953,547 | 5,814,114 | ||
Total current liabilities | 6,213,153 | 6,707,910 | 6,568,425 | ||
Long-term debt and finance lease obligations | 3,729,742 | 3,729,580 | 3,730,194 | ||
Income taxes payable | 667,639 | 646,044 | 603,412 | ||
Other long-term liabilities | 635,211 | 623,925 | 581,610 | ||
Total liabilities | 11,245,745 | 11,707,459 | 11,483,641 | ||
Stockholders' equity (2) | 10,145,426 | 10,192,752 | 9,861,619 | ||
Total liabilities and stockholders' equity | $ 21,391,171 | $ 21,900,211 | $ 21,345,260 | ||
(1) | Derived from audited financial statements. |
(2) | Common shares issued and outstanding were 1,251,180 as of December 28, 2025, 1,259,176 as of September 28, 2025, and 1,268,740 as of June 29, 2025. |
LAM RESEARCH CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands, unaudited) | |||||||||
Three Months Ended | Six Months Ended | ||||||||
December 28, | September 28, | December 29, | December 28, | December 29, | |||||
CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||
Net income | $ 1,593,994 | $ 1,568,660 | $ 1,191,018 | $ 3,162,654 | $ 2,307,462 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||
Depreciation and amortization | 103,925 | 101,644 | 96,200 | 205,569 | 190,495 | ||||
Deferred income taxes | (30,957) | (62,875) | (82,854) | (93,832) | (191,576) | ||||
Equity-based compensation expense | 88,539 | 97,241 | 81,959 | 185,780 | 161,970 | ||||
Other, net | (19,961) | (1,890) | (8,592) | (21,851) | (9,049) | ||||
Changes in operating assets and liabilities | (255,495) | 76,184 | (535,789) | (179,311) | (148,889) | ||||
Net cash provided by operating activities | 1,480,045 | 1,778,964 | 741,942 | 3,259,009 | 2,310,413 | ||||
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||||
Capital expenditures and intangible assets | (260,879) | (185,121) | (188,349) | (446,000) | (298,937) | ||||
Other, net | 3,096 | (927) | 12,974 | 2,169 | 13,011 | ||||
Net cash used for investing activities | (257,783) | (186,048) | (175,375) | (443,831) | (285,926) | ||||
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||
Principal payments on debt, including finance lease obligations and payments for debt issuance costs | (1,462) | (1,417) | (1,032) | (2,879) | (1,966) | ||||
Treasury stock purchases, including excise tax payments | (1,466,155) | (975,791) | (697,688) | (2,441,946) | (1,694,723) | ||||
Dividends paid | (327,507) | (291,981) | (297,634) | (619,488) | (558,619) | ||||
Reissuance of treasury stock related to employee stock purchase plan | 67,185 | — | 60,557 | 67,185 | 60,557 | ||||
Proceeds from issuance of common stock, net issuance costs | 3,854 | — | (194) | 3,854 | (237) | ||||
Other, net | (1,117) | (12,449) | 761 | (13,566) | 437 | ||||
Net cash used for financing activities | (1,725,202) | (1,281,638) | (935,230) | (3,006,840) | (2,194,551) | ||||
Effect of exchange rate changes on cash, cash equivalents, and restricted cash | (13,337) | (7,059) | (26,022) | (20,396) | (3,340) | ||||
Net change in cash, cash equivalents, and restricted cash | (516,277) | 304,219 | (394,685) | (212,058) | (173,404) | ||||
Cash, cash equivalents, and restricted cash at beginning of period (1) | 6,711,875 | 6,407,656 | 6,072,084 | 6,407,656 | 5,850,803 | ||||
Cash, cash equivalents, and restricted cash at end of period (1) | $ 6,195,598 | $ 6,711,875 | $ 5,677,399 | $ 6,195,598 | $ 5,677,399 | ||||
(1) | Restricted cash is reported within Other assets in the Condensed Consolidated Balance Sheets |
Non-GAAP Financial Summary (in thousands, except percentages and per share data) (unaudited) | |||
Three Months Ended | |||
December 28, | September 28, | ||
Revenue | $ 5,344,791 | $ 5,324,173 | |
Gross margin | $ 2,658,256 | $ 2,693,582 | |
Gross margin as percentage of revenue | 49.7 % | 50.6 % | |
Operating expenses | $ 827,486 | $ 831,916 | |
Operating income | $ 1,830,770 | $ 1,861,666 | |
Operating income as a percentage of revenue | 34.3 % | 35.0 % | |
Net income | $ 1,597,626 | $ 1,604,597 | |
Net income per diluted share | $ 1.27 | $ 1.26 | |
Shares used in per share calculation - diluted | 1,261,739 | 1,269,313 | |
Reconciliation of (in thousands, except per share data) (unaudited) | |||
Three Months Ended | |||
December 28, | September 28, | ||
$ 1,593,994 | $ 1,568,660 | ||
Pre-tax non-GAAP items: | |||
Amortization related to intangible assets acquired through certain business combinations - cost of goods sold | 2,668 | 2,687 | |
Elective deferred compensation ("EDC") related liability valuation increase - cost of goods sold | 4,426 | 6,016 | |
EDC related liability valuation increase - research and development | 7,968 | 10,828 | |
Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative | 193 | 538 | |
EDC related liability valuation increase - selling, general and administrative | 5,312 | 7,219 | |
Impairment of long-lived assets - selling, general and administrative | — | 5,290 | |
Amortization of note discounts - other income (expense), net | 701 | 695 | |
Gain on EDC related asset - other income (expense), net | (16,628) | (23,088) | |
Net income tax benefit on non-GAAP items | (1,008) | (1,698) | |
Income tax expense from a change in tax law | — | 27,450 | |
Non-GAAP net income | $ 1,597,626 | $ 1,604,597 | |
Non-GAAP net income per diluted share | $ 1.27 | $ 1.26 | |
$ 1.26 | $ 1.24 | ||
1,261,739 | 1,269,313 | ||
Reconciliation of (in thousands, except percentages) (unaudited) | |||
Three Months Ended | |||
December 28, | September 28, | ||
$ 2,651,162 | $ 2,684,879 | ||
Pre-tax non-GAAP items: | |||
Amortization related to intangible assets acquired through certain business combinations | 2,668 | 2,687 | |
EDC related liability valuation increase | 4,426 | 6,016 | |
Non-GAAP gross margin | $ 2,658,256 | $ 2,693,582 | |
49.6 % | 50.4 % | ||
Non-GAAP gross margin as a percentage of revenue | 49.7 % | 50.6 % | |
$ 840,959 | $ 855,791 | ||
Pre-tax non-GAAP items: | |||
Amortization related to intangible assets acquired through certain business combinations | (193) | (538) | |
EDC related liability valuation increase | (13,280) | (18,047) | |
Impairment of long-lived assets | — | (5,290) | |
Non-GAAP operating expenses | $ 827,486 | $ 831,916 | |
$ 1,810,203 | $ 1,829,088 | ||
Non-GAAP operating income | $ 1,830,770 | $ 1,861,666 | |
33.9 % | 34.4 % | ||
Non-GAAP operating income as a percent of revenue | 34.3 % | 35.0 % | |
Lam Research Corporation Contacts:
Ram Ganesh, Investor Relations, phone: 510-572-1615, e-mail: investor.relations@lamresearch.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/lam-research-corporation-reports-financial-results-for-the-quarter-ended-december-28-2025-302673080.html
SOURCE Lam Research Corporation
